The conversation you should have after an endometrial cancer diagnosis

Endometrial (uterine) cancer is most common after menopause, but diagnoses in younger women are rising, and women under 50 are now one of the fastest-growing groups being diagnosed. Over the past two decades, rates in this age group have steadily increased, even as awareness has lagged behind. It’s still not the typical patient, but it’s no longer rare. And that gap between perception and reality is exactly where important conversations, especially around fertility, are getting missed.

One woman was in the middle of preparing for IVF when she got the call that she had endometrial (uterine) cancer. She wasn’t expecting biopsy results, wasn’t worried, and wasn’t thinking about cancer at all. The procedure had been a routine part of getting ready to try for a baby. Within days, the conversation shifted from timelines for pregnancy to recommendations for a hysterectomy. The same process that was supposed to help her start a family suddenly forced her to consider losing that possibility altogether.

A standard treatment for endometrial (uterine) cancer is a hysterectomy. It is effective and, in many cases, the safest path forward. But it also means the end of being able to carry a pregnancy. When that reality isn’t part of the conversation early on, it can feel like something deeply personal was decided for you before you even knew there were questions to ask.

In certain early-stage cases, and with specific tumor characteristics, there may be an opportunity to consider fertility-sparing treatment. This usually involves hormone therapy, paired with very close monitoring, with the goal of controlling the cancer while keeping the uterus in place. These approaches are not widely applicable, and they’re not without risk. They require careful patient selection, ongoing follow-up, and a clear understanding that the plan may need to change if the cancer does not respond. Some women do very well and are able to move forward with pregnancy, sometimes with the help of fertility specialists. Others may not respond as hoped, or may ultimately need surgery after all. That uncertainty is part of the weight of the decision.

What makes this harder is that fertility is not always centered in early conversations. If preserving fertility is important to you, it’s worth raising early, even if you’re not sure what the answer will be. Understanding your specific diagnosis, including the stage, grade, and tumor type, can help clarify whether fertility-sparing approaches are even on the table. And when these approaches are successful, many specialists recommend trying to conceive sooner rather than later, given the risk of recurrence over time.

When faced with a cancer diagnosis, patients deserve more than a single path forward. They deserve to see the full picture of what might be possible and to understand how each option fits into their life, not just their diagnosis.

Outcomes4Me brings together personalized, evidence-based treatment options, clinical trial matching, and the questions you should be asking your care team, all in one place. Because making the right decision isn’t just about treating cancer. It’s about making sure your life, and the future you’re trying to build, are part of the conversation from the very beginning.